首页|达格列净对急性心肌梗死行急诊经皮冠状动脉介入治疗患者心功能的影响

达格列净对急性心肌梗死行急诊经皮冠状动脉介入治疗患者心功能的影响

扫码查看
目的 观察达格列净对急性ST段抬高型心肌梗死行急诊PCI后发生心力衰竭患者心功能的影响.方法 选取急性心肌梗死行急诊PCI的患者100例,随机分为研究组52例和对照组48例.研究组在心肌梗死规范化治疗的基础上给予达格列净,对照组给予心肌梗死常规治疗.比较2组治疗前及治疗6个月后心脏超声相关指标[左心室射血分数(LVEF)、左心室舒张末内径(LVEDD)、左心室收缩末内径(LVESD)、左心室舒张末容积(LVEDV)]、血浆N末端脑钠肽前体(NT-proBNP)水平、6 min步行试验(6MWT)结果.比较2组随访期间不良反应及主要心血管不良事件(MACE)的发生情况.结果 治疗6个月后,2组的LVESD、LVEDD、LVEDV低于治疗前,LVEF高于治疗前,差异有统计学意义(P<0.05);研究组的LVESD、LVEDD、LVEDV低于对照组,LVEF高于对照组,差异有统计学意义(P<0.05).2组的NT-proBNP低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05).研究组的6MWT距离长于对照组,差异有统计学意义(P<0.05).2组不良反应发生率、MACE发生率比较,差异无统计学意义(P>0.05).结论 达格列净对急性ST段抬高型心肌梗死行急诊PCI后发生心力衰竭患者的心功能具有改善作用.
Effect of dapagliflozin on cardiac function in patients with acute myocardial infarction after emergency percutaneous transluminal coronary intervention
Objective To observe the effect of dapagliflozin on cardiac function in patients with heart failure after emergency percutaneous transluminal coronary intervention in acute ST segment ele-vation myocardial infarction.Methods A total of 100 patients with acute myocardial infarction un-derwent emergency PCI were randomly divided into study group(52 cases)and control group(48 ca-ses).The study group was given dapagliflozin on the basis of standardized treatment of myocardial in-farction,and the control group was given conventional treatment of myocardial infarction.Cardiac ul-trasound related indexes[left ventricular ejection fraction(LVEF),left ventricular end-diastolic di-ameter(LVEDD),left ventricular end-systolic diameter(LVESD),left ventricular end-diastolic vol-ume(LVEDV)],plasma N-terminal brain natriuretic peptide(NT-proBNP)level,6-minute walking test(6MWT)results.The incidence of adverse reactions and major cardiovascular adverse events(MACE)were compared between the two groups during follow-up.Results After 6 months of treat-ment,LVESD,LVEDD and LVEDV in the two groups were significantly lower than before treatment,and LVEF was significantly higher than before treatment(P<0.05);the LVESD,LVEDD and LVEDV of the study group were significantly lower than those of the control group,and LVEF was sig-nificantly higher than that of the control group(P<0.05).The NT-proBNP in the two groups was significantly lower than before treatment,and was significantly lower in the study group than that in the control group(P<0.05).The 6MWT distance of the study group was significantly longer than that of the control group(P<0.05).There was no significant difference in the incidence of adverse reactions and MACE between the two groups(P>0.05).Conclusion Dapagliflozin can improve cardiac function in patients with heart failure after emergency PCI of acute ST segment elevation my-ocardial infarction.

acute myocardial infarctionpercutaneous transluminal coronary interventiondapagliflozinheart failure

张一、王岩、王阳、陶帅、齐蕊、苗瑞超、于海翔

展开 >

辽宁省阜新市第二人民医院/辽宁省阜新市妇产医院心内一科,辽宁阜新,123000

急性心肌梗死 经皮冠状动脉介入治疗 达格列净 心力衰竭

2024

实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
年,卷(期):2024.28(3)
  • 18